Med Sci Sports Exerc. 1993 Oct;25(10):i-x.
Hypertension is present in epidemic proportions in adults of industrialized societies and is associated with a markedly increased risk of developing numerous cardiovascular pathologies. There is a continuing debate as to the efficacy of aggressive pharmacological therapy in individuals with mild to moderate elevations in blood pressure. This has led to a search for nonpharmacological therapies, such as exercise training, for these individuals. The available evidence indicates that endurance exercise training by individuals at high risk for developing hypertension will reduce the rise in blood pressure that occurs with time. Thus, it is the position of the American College of Sports Medicine that endurance exercise training is recommended as a nonpharmacological strategy to reduce the incidence of hypertension in susceptible individuals. A large number of studies indicate that endurance exercise training will elicit a 10 mm Hg average reduction in both systolic and diastolic blood pressures in individuals with mild essential hypertension (blood pressures 140-180/90-105 mm Hg). Endurance exercise training also has the capacity to improve other risk factors for cardiovascular disease in hypertensive individuals. Endurance exercise training appears to elicit even greater reductions in blood pressure in patients with secondary hypertension due to renal dysfunction. The mode (large muscle activities), frequency (3-5 d.wk-1), duration (20-60 min), and intensity (50-85% of maximal oxygen uptake) of the exercise recommended to achieve this effect are generally the same as those prescribed for developing and maintaining cardiovascular fitness in healthy adults. Exercise training at somewhat lower intensities (40-70% VO2max) appears to lower blood pressure as much, or more, than exercise at higher intensities, which may be important in specific hypertensive populations. Physically active and fit individuals with hypertension have markedly lower rates of mortality than sedentary, unfit hypertensive individuals. Thus, it seems reasonable to recommend exercise as the initial treatment strategy for individuals with mild to moderate essential hypertension. A follow-up period should assess the efficacy of the patient's exercise program, and adjunct therapies should be implemented according to the individual patient's blood pressure and CAD risk factor goals. Individuals with more marked elevations in blood pressure (> 180/105 mm Hg) should add endurance exercise training to their treatment regimen only after initiating pharmacologic therapy. Resistive, or strength, exercise training is not recommended to lower blood pressure in individuals with hypertension when done as their only form of exercise training.(ABSTRACT TRUNCATED AT 400 WORDS)
高血压在工业化社会的成年人中呈流行态势,并且与患多种心血管疾病的风险显著增加相关。对于血压轻度至中度升高的个体,积极的药物治疗效果如何,一直存在争议。这促使人们为这些个体寻找非药物治疗方法,如运动训练。现有证据表明,高血压高危个体进行耐力运动训练可降低随时间推移而出现的血压升高。因此,美国运动医学学院的立场是,推荐耐力运动训练作为一种非药物策略,以降低易感个体患高血压的发生率。大量研究表明,轻度原发性高血压患者(血压为140 - 180/90 - 105 mmHg)进行耐力运动训练后,收缩压和舒张压平均可降低10 mmHg。耐力运动训练还有能力改善高血压个体的其他心血管疾病风险因素。对于因肾功能不全导致的继发性高血压患者,耐力运动训练似乎能使血压降低得更多。为达到此效果所推荐的运动方式(大肌肉活动)、频率(每周3 - 5天)、持续时间(20 - 60分钟)和强度(最大摄氧量的50 - 85%),通常与为健康成年人发展和维持心血管健康所规定的相同。强度稍低(最大摄氧量的40 - 70%)的运动训练似乎能使血压降低的幅度与高强度运动相同,甚至更大,这在特定高血压人群中可能很重要。积极运动且健康的高血压个体的死亡率明显低于久坐不动、不健康的高血压个体。因此,对于轻度至中度原发性高血压患者,推荐运动作为初始治疗策略似乎是合理的。应通过随访期评估患者运动计划的效果,并根据个体患者的血压和CAD风险因素目标实施辅助治疗。血压升高更明显(> 180/105 mmHg)的个体,应在开始药物治疗后,才将耐力运动训练添加到治疗方案中。当阻力运动训练(即力量训练)作为高血压个体唯一的运动训练形式时,不建议用于降低血压。(摘要截选至400字)